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The Aurora kinases are essential regulators of mitosis in eukaryotes. In somatic cell 
divisions of higher eukaryotes, the paralogs Aurora kinase A (AurA) and Aurora kinase 
B (AurB) play non-overlapping roles that depend on their distinct spatiotemporal activ-
ities. These mitotic roles of Aurora kinases depend on their interactions with different 
partners that direct them to different mitotic destinations and different substrates: AurB 
is a component of the chromosome passenger complex that orchestrates the tasks of 
chromosome segregation and cytokinesis, while AurA has many known binding partners 
and mitotic roles, including a well-characterized interaction with TPX2 that mediates 
its role in mitotic spindle assembly. Beyond the spatial control conferred by different 
binding partners, Aurora kinases are subject to temporal control of their activation and 
inactivation. Ubiquitin-mediated proteolysis is a critical route to irreversible inactivation of 
these kinases, which must occur for ordered transition from mitosis back to interphase. 
Both AurA and AurB undergo targeted proteolysis after anaphase onset as substrates 
of the anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase, even while 
they continue to regulate steps during mitotic exit. Temporal control of Aurora kinase 
destruction ensures that AurB remains active at the midbody during cytokinesis long after 
AurA activity has been largely eliminated from the cell. Differential destruction of Aurora 
kinases is achieved despite the fact that they are targeted at the same time and by the 
same ubiquitin ligase, making these substrates an interesting case study for investigating 
molecular determinants of ubiquitin-mediated proteolysis in higher eukaryotes. The prev-
alence of Aurora overexpression in cancers and their potential as therapeutic targets add 
importance to the task of understanding the molecular determinants of Aurora kinase 
stability. Here, we review what is known about ubiquitin-mediated targeting of these 
critical mitotic regulators and discuss the different factors that contribute to proteolytic 
control of Aurora kinase activity in the cell.
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iNTRODUCTiON
Aurora kinases are critical regulators of eukaryotic cell division. Their structure, activities, and 
functions have been extensively reviewed elsewhere (1–4) and will be mentioned only briefly here. 
Although Aurora kinases share a high degree of homology in their kinase domains, they play distinct 
roles in cell division (Figure 1). Aurora A (AurA) is an upstream element in the cascade of kinase 
FiGURe 1 | events during mitotic exit that are influenced by Aurora kinases, illustrated against their degradation profiles. Blue, AurA; red, AurB.
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activities that control progression from G2 to M phase (through 
Bora-mediated activation of Plk1) and further plays direct roles 
in the maturation of the centrosome, in microtubule (MT) 
nucleation, and in the activation of other components required to 
build a bipolar mitotic spindle. AurA has a large number of sub-
strates and interactors and alternative modes of activation, with 
different partners thought to give rise to distinct pools of active 
kinase. Aurora B (AurB), on the other hand, resides as an obliga-
tory component of the chromosome passenger complex (CPC; 
along with INCENP, survivin, and borealin), which is essential 
for chromosome condensation and organization during mitosis, 
including a critical role as an effector of the mitotic checkpoint in 
regulating kinetochore-MT attachments on the mitotic spindle. 
Both Auroras have a predicted disordered N-terminus. This 
disordered region is more extensive in AurA and is found to 
mediate much of the specificity in AurA interactions, including 
those required for its functions at the centrosome (5).
It is striking that a version of AurA bearing a single-point 
mutation that switches its major mitotic interaction from TPX2 
to INCENP can rescue knockdown of AurB (6, 7), and consist-
ent with this observation, the two kinases appear to have many 
shared substrates. Other, specific, AurA or AurB substrates are 
likely to be constrained in their specificity in a cellular context 
through colocalization with one or other of the Auroras (8–11). 
Perhaps not surprisingly then, some lower eukaryotes were 
found to have a single Aurora kinase that carries out roles at 
both centrosomal and chromosomal locations and which can 
functionally substitute for either AurA or AurB in mammalian 
cells (12, 13). Spatial organization of Aurora kinase activity is 
thus thought to have arisen through the acquisition of different 
binding partners. The divergence of AurA and AurB functions in 
higher eukaryotes presents an interesting paradigm of differential 
regulation of kinase activity at specific subcellular domains. One 
of the elements contributing to such spatiotemporal regulation is 
differential targeted proteolysis.
The discovery of the ubiquitin–proteasome system (UPS) 
for targeted destruction of proteins (proteolysis) provided the 
framework for understanding how mitotic exit is driven by the 
activity of a multisubunit ubiquitin ligase complex known as 
the anaphase-promoting complex/cyclosome (APC/C) (14, 15). 
Targeting of securin and mitotic cyclins by the APC/C is neces-
sary and sufficient for chromosome segregation and mitotic 
exit, respectively. Two decades of research on the APC/C have 
elucidated many features of its action and identified a large num-
ber of additional targets, which include the Aurora kinases. How, 
and why, the APC/C targets many different substrates with high 
temporal specificity remains an intriguing question in mitosis 
control. A resetting of the protein landscape of the cell must occur 
in preparation for interphase, for example, to rid the cell of factors 
that contributed to the assembly of the mitotic spindle. In some 
cases, however, it has been shown that the destruction of specific 
substrates contributes to the orderly progression of mitotic exit 
(16–19). Aurora kinases are two such substrates whose targeting 
by the APC/C and its coactivator Cdh1 contributes to the correct 
dosing, timing, and localization of their activities (17, 19).
There is now a substantial body of literature pointing to 
additional, non-mitotic roles of AurA, indicating a requirement 
for regulating Aurora kinase activity in interphase. It seems 
likely that a substantial fraction of AurA is protected from 
APC/C–Cdh1 activity in G1 phase, since APC/C–Cdh1 activity 
is predominantly nuclear (20–22) and AurA largely cytoplasmic 
(in contrast to AurB, which is strongly localized to the nucleus). 
Therefore, alternative UPS pathways may regulate cytoplasmic 
AurA outside of mitosis, and a number of candidate UPS compo-
nents are reported in the literature.
The importance of regulating Aurora kinase activity is well 
established. In this review, we will consider the importance of 
proteolysis for the activity of Aurora kinases in mitosis and in 
interphase and what is known about mechanisms of Aurora 
kinase proteolysis. A bias in our review toward AurA reflects 
the fact that far more is known about proteolysis of this Aurora 
paralog in higher eukaryotes.
wHY ARe AURORA KiNASeS TARGeTeD 
FOR PROTeOLYSiS?
Spatiotemporal Organization of Aurora 
Kinase Activity Through the Cell Cycle
Proteolytic pathways have been shown to effect dosage compen-
sation to enforce stoichiometric expression of the components 
of multiprotein complexes (23), and indeed, both AurA and 
AurB are destabilized by the loss of respective interaction 
partners TPX2 and INCENP (24, 25). This observation may be 
widely applicable to proteins, such as Aurora kinases, contain-
ing short linear interaction motifs (SLiMs) (26) within extended 
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unstructured regions. SLiMs can adopt specific structures upon 
interaction. Various pools of AurA act through different inter-
actors, generating structures with distinct autophosphorylation 
profiles (for example, interaction with nucleophosmin gener-
ates a phospho-Ser89 epitope in an active pool of AurA distinct 
from that activated by phosphorylation in the T-loop at Thr288) 
(27). Destabilization could be a default mode to constrain 
Aurora kinase activity unless protected by interaction, helping 
to maintain distinct, spatially defined pools of AurA and AurB 
activities.
We note that during early mitosis, the APC/C is proposed to 
play a role in “dosing” spindle-associated factors by eliminating 
components in excess of those required for the assembly of the 
correctly sized bipolar mitotic spindle (28). In this model, bind-
ing to MTs directly stabilizes proteins, such as HURP, which are 
otherwise turned over rapidly by the APC/C. We speculate that 
such default targeting by the APC/C could be a characteristic of 
mitotic regulators that assists their clearance from the cell as the 
machinery of cell division disassembles at the end of mitosis.
execution of Mitotic exit
Aurora kinases play critical roles in orchestrating events at 
mitotic exit (Figure  1). Elucidating them has been a challeng-
ing task, given the multiple functions of the Auroras earlier in 
mitosis. In recent years, however, the use of chemical genetics and 
development of specific small molecule inhibitors have helped 
decrypt roles of Aurora kinases after anaphase onset. Activity of 
either AurA or AurB is essential for disassembly of the metaphase 
spindle (29). Furthermore, AurA activity is required for anaphase 
spindle dynamics and central spindle formation, with AurA 
inhibition reducing anaphase pole-to-pole separation, resulting 
in a disorganized midzone with sparse MTs. Although the exact 
molecular mechanism remains to be elucidated, TACC3 and 
the dynactin subunit p150Glued have been identified as AurA 
substrates mediating anaphase spindle elongation (27, 30, 31). 
AurB plays critical roles during anaphase as the CPC relocates 
to the midzone of the anaphase spindle and from thence to the 
equatorial cortex, where AurB activity is essential for furrowing 
(32, 33). At the completion of cytokinesis, AurB is found on MTs 
flanking the midbody, where it retains activity to control the 
timing of abscission through the CHMP4C component of the 
ESCRTIII complex (34–37).
Downregulating Aurora kinase activity is also important for 
mitotic exit. The activation of counteracting phosphatases (38) 
does not appear sufficient to reverse the functional phospho-
rylation events mediated by the Auroras, since non-degradable 
versions perturb the organization of mitotic exit. The gain-of-
function phenotypes exhibited by non-degraded Auroras could 
point to kinase-independent roles, but more likely mean that 
the kinases retain some activity when dephosphorylated in the 
activation loop (39). We propose therefore that targeted Aurora 
degradation, as a tool for tuning the activity of the kinases, is a 
critical element of their functions in mitotic exit.
In Cdh1 knockdown, consequently, anaphase spindle organi-
zation is perturbed, and the spindle over-elongated, in a fashion 
that can be rescued by codepletion of AurA and mimicked by 
expression of non-degradable AurA (17). AurA, p150, and 
TACC3 may act to translate the precise downregulation of AurA 
into remodeling of the anaphase MT network. Cleavage furrow 
ingression occurs earlier in Cdh1 knockdown than in control 
cells and is accompanied by the premature appearance of AurB 
at the equatorial cortex (19). Whether this effect is mediated 
through stabilization of AurB, through disruption of the central 
spindle caused by stabilization of AurA, or through a different 
Cdh1 substrate, is not known. The effect of Cdh1 knockdown 
on abscission timing has not been reported, but stabilization of 
AurB is likely to delay this process, as well as contributing to the 
genomic instability reported in Cdh1−/− MEFs (40).
establishing interphase
Several mitotic processes that depend on Aurora activity must 
be reversed as cells return to interphase. Reorganization of the 
cell cytoskeleton requires degradation of AurA for disassembly of 
spindle poles and of AurB for formin-mediated cell spreading (17, 
19). For other processes, such as AurA-mediated mitochondrial 
fissioning (41), the role of Aurora degradation has not yet been 
established. Ubiquitination of AurB is proposed to be required for 
its p97-dependent extraction from chromatin to allow chromo-
some decondensation and nuclear envelope formation (42). More 
generally, tuning of AurB activity may tie the timing of abscission 
to the state of the nucleus at the passage to interphase: AurB activ-
ity has been proposed to delay abscission in response to delays in 
nuclear pore assembly (43), and recent studies show that the same 
ESCRT machinery regulated by AurB in the process of abscis-
sion is involved in resealing the nuclear envelope at the start of 
interphase (44, 45). A gradient of AurB activity emanating from 
the midzone is proposed to coordinate these events with sister 
chromatid separation in a checkpoint-like manner (46). What has 
become increasingly apparent is that AurB acts as both sensor 
and effector in the transition from mitosis to interphase, with 
its activity carefully modulated through localization, exposure 
to phosphatases, and degradation. This role for AurB provides a 
rationale for the very different degradation kinetics of AurA and 
AurB observed at the end of mitosis (Figure 2).
Regulating Cell Fate
A substantial body of literature points to additional, non-mitotic 
roles of Aurora kinases. AurA is required for reabsorption of 
the primary cilium in serum-stimulated quiescent cells and for 
migration of postmitotic neurons during development (49, 50). 
Both AurA and AurB are implicated in cell fate decisions, AurA 
through effects on stability of N-myc and p53, GSK3 signaling, 
and Notch pathways (51–55) and AurB through modulating the 
epigenetic states of histone H3, for example, in maintaining the 
differentiated state of C2C12 myoblasts and in transient tran-
scriptional reprograming of events in interphase nuclei (56–58). 
As already shown for the role of AurA in postmitotic neurons, 
the activities of Aurora kinases in each of these processes could 
be regulated by proteolysis (50).
Proteostasis and Cancer
The systematic overexpression of AurA in cancers was noted 
early on after the discovery of Aurora kinases (59, 60) and is now 
recognized as an important driver of many cancer types, often 
FiGURe 2 | Kinetics of Aurora kinase destruction during mitotic exit. (A) Total levels of Venus-tagged AurA and AurB in cells passing through mitosis. Data 
taken from Min et al. (47). Fluorescence measurements from single cells were used to generate averaged progress curves for the degradation of each substrate 
(n ≥ 50). (B) Plots of the changing rate of degradation over time for the averaged progress curves show that the maximum rate of AurA degradation is fivefold higher 
than that of AurB. (C) Simulation of first-order (Michaelis–Menten) kinetics predicts a theoretical degradation curve showing an exponential decrease in substrate 
levels over time that resembles the degradation curves that we have previously described for other substrates of the APC/C, such as Plk1, RacGAP1, and KIFC1 
(16, 48), and is consistent with the idea that for these substrates, ubiquitination is the single rate-limiting step for proteolysis (since the rate of proteolysis depends 
on the amount of substrate present). (D) Modeling of distributive ubiquitination of a substrate, where a threshold number of stepwise ubiquitin modifications is 
required to generate the product that can be processed for proteasomal degradation, compared to a processive ubiquitination process. The simulated reaction 
exhibits the sigmoidal/switch-like response that characterizes degradation of AurA. (e) Schematic to explain kinetics of degradation of different substrates. 
Processive ubiquitination of substrates, such as Plk1, is achieved by a single binding event to the APC/C, and substrates rate limited by single-step ubiquitination 
are degraded with first-order kinetics. By contrast, Aurora kinases bind to the APC/C multiple times to acquire polyubiquitin chains. AurA, rate-limited by this 
multistep ubiquitination, exhibits switch-like degradation kinetics. Degradation of AurB is likely governed by a post-ubiquitination step.
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as a result of amplification of the AurA gene, located on the 20q 
amplicon (for example, the most common amplicon in colorectal 
cancer) (61, 62). AurA is thought to contribute to chromosome 
instability (CIN) during mitosis through its effects on MT 
dynamics (63), raising the possibility that control of AurA levels is 
required to protect cells from CIN (64). The functions of Aurora 
kinases in interphase could also contribute to the tumorigenic 
nature of AurA overexpression – perhaps more efficiently than 
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functions in promoting chromosome segregation in mitosis. 
Notably, kinase-independent roles, such as the  protein–protein 
interaction between AurA and MYCN protein that stabilizes 
MYCN in neuroblastoma (53), provide a link between regulation 
of AurA levels and proliferation. Drugs that disrupt the AurA–
MYCN interaction may offer a therapeutic route to treating 
neuroblastoma (65).
To what extent, then, is pathological expression of AurA a 
problem with regulation of protein stability? One model for con-
ditional AurA overexpression showed that in vivo overexpression 
of mouse AurA from a transgene did not result in increased 
AurA protein levels, since these were suppressed by proteolysis 
under physiological conditions (66). A recent proteogenomic 
survey of colorectal cancer reported that, in general, mRNA 
overexpression driven by gene amplifications was not reflected 
in overexpression at the protein level, suggesting that the latter 
is buffered by posttranscriptional regulation (62). Therefore, 
overexpression of AurA protein in cancers may indicate changes 
in the stability of the protein, either changes in AurA or in the 
pathways that regulate it. For example, stabilization of AurA 
through constitutive phosphorylation of a critical residue, Ser51, 
has been reported in head and neck cancers (67). Coexpression 
of TPX2 may be another route to stabilizing AurA in cancers, 
contributing to excess AurA activity after 20q amplification, 
since AURKA and TPX2 are both located on the long arm of 
chromosome 20 (68).
In the following sections of this review, we will discuss factors 
that determine, or influence, the ubiquitin-mediated regulation 
of Aurora kinase levels in the cell.
THe KiNeTiCS OF AurA AND AurB 
DeGRADATiON AT MiTOTiC eXiT
In mammalian cells, anaphase substrates of the APC/C fall into 
groups that show distinct kinetics of degradation when meas-
ured in single cell assays in vivo. These kinetics are determined 
by the multilayered complexity of the UPS, which includes post-
translational modifications (PTMs) on substrates (and on the 
APC/C) and other characteristics of substrate interactions with 
the APC/C that determine the on-rate and the residence time 
of the substrate (69). The activity of deubiquitinating enzymes 
(DUBs) and of other ubiquitin modifiers can also influence 
the degradation of ubiquitinated substrates, and the p97 AAA-
ATPase may be required to unfold ubiquitinated substrates to 
render them accessible for degradation (70). The topology of 
ubiquitinated substrates undoubtedly influences their interac-
tion with the proteasome, since polyubiquitin chains and an 
unstructured region that serves as the degradation initiation 
region need to be in the right proximity to one another for 
proteasomal proteolysis (71).
In vivo assays of GFP-tagged Aurora kinases report on the 
timing and kinetics of their degradation, which begins 10 min 
after anaphase onset (Figure 2A) (47). The timing of degradation 
onset for AurA and AurB is identical by this assay. However, their 
rates of degradation are very different (Figure 2B), explaining the 
long-standing observation that AurA is removed from the cell 
well ahead of AurB during mitotic exit (16, 17, 72, 73).
Progress curves for substrate degradation can provide infor-
mation on the kinetics of the underlying reactions. The progress 
curve of GFP Venus-tagged AurA is consistent with the idea that 
distributive (stepwise) ubiquitination of AurA determines the 
kinetics of disappearance of this substrate (Figures  2A,C,D). 
AurA was previously shown to be a distributive substrate in vitro, 
where building a proteolytic ubiquitin chain requires multiple 
rounds of substrate–APC/C binding each binding event consid-
ered an independent and reversible step (69, 74) (Figure 2E). In 
contrast to the switch-like kinetics of AurA-Venus degradation, 
AurB-Venus degradation progressed at a rate that was slow but 
constant – even when AurB-Venus levels were low (Figures 2A–
C) – with the inference that degradation is governed by a rate-
limiting step with low catalytic activity and high affinity of the 
rate-limiting enzyme for the substrate (75). Since both substrates 
appear ubiquitinated to the same extent during mitotic exit (47, 
76), we propose that this rate-limiting step in AurB degradation 
occurs post-ubiquitination. We note that both of these progress 
curves are distinct from those of other substrates we have studied, 
such as Plk1 and KIFC1 (16, 48), which show first-order (or 
Michaelis–Menten) kinetics (rate of disappearance dependent on 
substrate concentration) (Figures 2C,D). First-order kinetics is 
consistent with a model where processive (single-step) substrate 
ubiquitination would be rate limiting for degradation. It seems 
therefore that distinct steps in processing of the Aurora kinases 
underlie their characteristic degradation curves and differential 
removal from the cell (Figure 2E).
HOw ARe AURORA KiNASeS TARGeTeD 
iN MiTOTiC eXiT?
Aurora Kinases Are Cdh1-Dependent 
Substrates of the APC/C
AurA was found early on to be an efficiently degraded substrate of 
the APC/C (77). Its efficient degradation in in vitro assays using 
extracts from human cells or Xenopus oocytes has facilitated 
identification of substrate-specific determinants of degradation 
(78–81). The APC/C relies on either of the two coactivators, 
WD40 repeat factors Cdc20 or Cdh1 (FZR1 in humans). AurA is 
specifically targeted by Cdh1 in vitro (79, 80, 82) and is robustly 
stabilized by depletion of Cdh1 in various systems (17, 40, 72). 
Recombinant AurB is not degraded efficiently in the same in vitro 
assays (78), but AurB levels are highly sensitive to Cdh1 in cell-
based assays (17, 47, 72, 83).
The specificity of the APC/C for its substrates shifts as cells 
pass through mitosis. As cells enter anaphase, specificity switches 
from a relatively restricted pool of substrates to a large one that 
may number in the hundreds (76, 84). Although the switch from 
Cdc20 to Cdh1 was originally thought to account for this change 
in specificity (85), it is now evident that a majority of substrates 
are efficiently degraded during mitotic exit in the absence of 
Cdh1, through altered targeting specificity of APC/C–Cdc20 (17, 
47, 72, 73, 86). For these substrates, therefore, the requirement for 
Cdh1 only reveals itself in G1 phase, or in in vitro assays, when 
the APC/C is in a dephosphorylated state that cannot interact 
with Cdc20. The strict dependence of AurA and AurB targeting 
FiGURe 3 | Conserved degrons in Aurora kinases. (A) Aurora kinase degrons are the most conserved motifs outside the kinase domain. The sequence 
alignment of AurA and AurB was converted to a vector of values corresponding to conservation at each position (from 4 for fully conserved position to 0 for no 
conservation). Rolling averages of a five-residue window across the whole alignment is presented as a heat map. Therefore, the shade of red indicates residue 
conservation between the two paralogs. (B) Degradation plots for A-box- (including S51-) and D-box-mutated versions of AurA-GFP, as described in Ref. (81). 
Fluorescence levels measured over time in single cells exiting mitosis are normalized to anaphase onset. ΔA-box = Δ31–66; D-box mutant = R371A, L374A.  
(C) Mitotic localization of mutants analyzed in (B), showing loss of functional localization of the D-box mutant.
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on Cdh1, even when APC/C–Cdc20 is active, marks them out 
from other APC/C substrates. Only Cdc6 is known to share 
this specificity (86), and we propose that the shared timing of 
destruction of these substrates signals the moment of activation 
of APC/C–Cdh1 in mitotic exit.
The unique specificity of Aurora kinases and Cdc6 is probably 
determined by the way in which they interact with the APC/C. 
It is well known that APC/C substrates contain receptor motifs, 
the so-called degrons, which are recognized and bound by 
coactivator-associated APC/C (87, 88). Now, structural studies 
[recently reviewed in Ref. (89)] are able to show the direct binding 
of coactivators, via their WD40-repeat propellors, to canonical 
degrons in substrates. However, although Aurora kinases contain 
such canonical degron motifs (D-boxes and KEN motifs), it is 
not clear what roles these play, since an additional non-canonical 
degron, called the “A-box” is also present (79) (Figure 3).
Aurora Kinases Contain Multiple Degrons
Canonical Degrons
APC/C substrates are usually characterized by the presence of 
a D-box (“destruction box,” consensus RxxL), first identified in 
the N-terminus of B-type cyclins (90). However, the D-box alone 
may not be sufficient for productive binding of most substrates: 
APC/C–substrate interactions are more likely governed by the 
weak interactions through multiple degrons categorized as SLiMs 
(91, 92). The most important of these additional degrons is the 
KEN motif, first identified in Cdc20, which lacks a D-box (88). 
The KEN motif binds to a different surface of the coactivator 
WD40 domain to the D-box, and is prevalent in APC/C substrates 
(and in 8% of the proteome). Aurora kinases contain conserved 
D-boxes and a KEN motif (Figure 3A). In vitro degradation assays 
identify the functional D-box of Aurora kinases as that conserved 
in a position close to the C-terminal end of the kinase domain 
(79, 81–83, 93). However, the orientation of the RxxL within the 
known structure of the kinase domain (94, 95) raises a question 
mark over how it could be accessible to the APC/C. Mutation of 
this motif not only abrogates the destruction of GFP-tagged AurA 
in cells undergoing mitotic exit but also abolishes the localization 
of AurA to any mitotic structures, rendering in vivo assessment of 
its role problematic (Figures 3B,C).
It is notable that all mitotic interactions of Aurora kinases are 
acutely sensitive to disruption in the C-terminal region (96, 97). 
Structural simulations of AurA–TPX2 interaction predict that 
the cancer-associated somatic mutation S155R in AurA, which 
prevents interaction with TPX2 (97), increases disorder in the 
C-terminus (98). Therefore, interaction with binding partners 
through the C-terminus maintains the overall structure of the 
kinases. Loss of critical interactions could allow partial unfold-
ing of Aurora kinases prior to targeting of the D-box by the 
APC/C, explaining the destabilization seen after loss of TPX2 or 
INCENP (24, 25).
An alternative idea, where the D-box is not assumed to 
function as a degron, is that the C-terminus of Aurora kinase is 
required for an intramolecular interaction, such as that proposed 
for AurA (99), influencing the structure of the N-terminus. The 
structure of the N-terminus could, in turn, determine the avail-
ability of SLiM-type degrons in the N-terminus for targeting by 
the ubiquitination machinery.
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Among these SLiMs are the Aurora KEN close to the 
N-terminus and the “A-box.” Despite multiple reports from 
in vitro studies that KEN plays no role in AurA mitotic destruc-
tion (79, 80, 82, 93), it contributes to the degradation in cell-based 
assays of both AurA and AurB (19, 100, 101). However, the AurA 
K5 within the KEN motif is ubiquitinated during mitotic exit 
(101), in apparent conflict with function as a degron. Structural 
or cross-linking studies of KEN interactions will be required to 
resolve the function of this motif. The A-box appears to qualify 
as a degron since the A-box-deleted version of AurA localizes 
correctly in mitosis and is resistant to mitotic exit degradation 
(Figures 3B,C).
The A-Box, a Specific Determinant of Aurora Kinase 
Destruction
The A-box motif was identified in AurA (residues 31–66) as the 
sequence required for APC/C–Cdh1-mediated destruction of 
AurA in mitotic/G1 extracts (79). More recent studies indicate 
that Q45RVL – conserved in AurB – is sufficient to mediate degron 
function in both kinases (67, 81, 100).
The A-box is predicted to mediate an atypical degron interac-
tion with APC/C–Cdh1, but the structural basis for this specificity 
has not been investigated. To our knowledge, the only structurally 
defined contributor of specificity for Cdh1 is the “A-motif ” found 
in APC/C inhibitor Acm1 in yeast (91, 102). Distinct from the 
Aurora A-box, the “A-motif ” is a 10 amino acid loop, including 
a key FxLxYE region that interacts with a non-canonical binding 
site on Cdh1 via a salt bridge and two hydrophobic interactions. 
Aurora kinases may employ an equivalent strategy in assembling 
substrate-specific APC/C–coactivator–E2 complexes, as dis-
cussed below.
Aurora Kinases Are Ube2S-Dependent 
Substrates of the APC/C
The APC/C ubiquitinates its targets in conjunction with two E2 
enzymes, Ube2C (UbcH10) and Ube2S. Ube2C adds the first, or 
“priming,” ubiquitin, and can generate short chains on substrates, 
while Ube2S elongates ubiquitin chains through the addition of 
K11-specific ubiquitin linkages (103, 104).
K48 linkages are the canonical proteasomal degradation 
signal, while K11 linkages have recently been found to mediate 
rapid degradation of mitotic substrates (47, 105, 106). The two 
E2s bind non-competitively to the APC/C (UbcH10 via the RING 
domain subunit APC11 and Ube2S via APC2), acting together 
as a highly efficient module for rapid targeting of substrates to 
the proteasome. The coactivators Cdc20 and Cdh1, as well as 
participating in substrate recognition, also promote the activity 
of APC/C through a critical substrate-induced stabilization of E2 
binding to the APC/C (92, 107, 108).
Our own work has shown that Aurora kinases are decorated 
with a mixture of K48- and K11-linked ubiquitin chains during 
mitotic exit, and that Ube2S is essential both for the K11 link-
ages and for efficient degradation of these substrates (47). Other 
substrates are able to receive K11 chains in the absence of Cdh1 
(presumably via Cdc20–Ube2S), while in Cdh1-depleted cells, 
Aurora kinases lose all their K11 chains but are still ubiquitinated 
with K48 chains in an APC/C-dependent manner, presumably 
because Ube2C recruitment can still occur (47). In other words, 
Aurora degradation depends on Cdh1 not for recruitment to the 
APC/C, but for generating K11 linkages via Ube2S (Figure 4).
why Cdh1 Specificity?
The functional significance – if there is any – of exclusive target-
ing by Cdh1 is not clear. Cdh1 could be specifying the timing of 
Aurora kinase destruction with respect to anaphase functions. It 
has been shown that APC/C–Cdh1 assembly depends on prior 
anaphase Plk1 destruction (109), thus the exclusive targeting of 
Aurora kinases by Cdh1 imposes strict order on the destruction 
of these substrates; Plk1 ahead of AurA (16). In the case of the 
replication factor Cdc6, which shows identical coactivator speci-
ficity and degradation timing to AurA, it is suggested that delayed 
degradation with respect to the licensing inhibitor geminin, a 
substrate of APC/C–Cdc20, creates a short but clearly defined 
window of opportunity for replication licensing during mitosis 
(86). Similarly, there may be an event in mitotic exit that requires 
Aurora kinase activity in the absence of Plk1 or some other Cdc20 
substrate.
An alternative explanation for the Cdh1 specificity is suggested 
by the progress curve of AurA degradation (Figure 2) (47). The 
“switch-like” kinetics imparts robustness to the destruction of 
this substrate once a cell is committed to mitotic exit (activa-
tion of Cdh1) and may depend on low processivity arising from 
weak Cdh1-substrate interactions. Finally, specificity for Cdh1 
may introduce possibilities for modulating the degradation 
of substrates via chain editing –  for example, the DUB USP37 
interacts with APC/C–Cdh1 to modulate K11 linkages on at least 
one substrate (110).
ReGULATiON OF AURORA KiNASe 
DeGRADATiON
Posttranslational Modification of Aurora 
Kinases
Recent advances in proteomics have not only started to reveal the 
identity of in vivo ubiquitination sites (111), but also the complex-
ity of PTMs that can modify the fate of target proteins. Tens of 
thousands of ubiquitinated lysines are known, although mostly 
these lack functional annotations. We find it interesting that only 
four endogenously ubiquitinated sites have been found for AurA 
but a large number for AurB (18 out of 22 lysines). Many of these 
ubiquitination sites are likely to serve non-proteolytic functions, 
by creating or disrupting interfaces with other partners. For 
example, CUL3-KHLH9/13/21-dependent ubiquitination is 
required for the correct localization of AurB in anaphase (112, 
113). We have found it necessary to disrupt multiple lysines in the 
N-terminus of AurB to significantly disrupt AurB degradation in 
mitotic exit (Mingwei Min, Catherine Lindon, unpublished data), 
suggesting that several or all of these ubiquitinated lysines could 
carry chains that contribute to processing of AurB at the protea-
some. The same is not true for AurA, which seems to rely strongly 
on its most N-terminal lysine, K5 (101) for mitotic exit degrada-
tion. This difference in lysine usage could explain the differential 
FiGURe 4 | Schematic illustrating the complexity of APC/C substrate specificity after anaphase onset. Most substrates can be targeted by either 
APC/C–Cdc20 or APC/C–Cdh1, working with both Ube2C and Ube2S (blue stream). Cdh1-only substrates, although they can still bind Cdc20, show restricted 
targeting by the APC/C–Ube2S that depends on Cdh1 (red stream). APC/C–Ube2S is required to generate the K11 linkages for rapid degradation at the 
proteasome.
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degradation kinetics that we measure for the two substrates, for 
example, if removal of ubiquitin chains at the proteasome prior 
to proteolysis is slow, as has been suggested (114).
Lysines can be subject to several PTMs beyond ubiquitina-
tion. Functionally important sumoylation of both Aurora 
kinases has been reported to occur on conserved lysines that 
are also reportedly ubiquitinated (in humans, AurA K258 and 
AurB K202), but it is not known how this might have impact on 
potential ubiquitination at these sites (115–117). The deacetylase 
SIRT2 has been found to strongly regulate both AurA and AurB 
levels in vivo (proposed to explain the high rate of tumorigenesis 
in SIRT2−/− mice) (118). Investigation of the underlying mecha-
nism was unable to detect acetylation on AurA lysine residues, 
but found that acetylation of APC/C coactivators interferes 
with their function. Aurora-specific recruitment of SIRT2 could 
therefore act to promote Aurora degradation, either directly 
or indirectly. We note that recent work showing acetylation on 
ubiquitin as a potential route to switches in chain specificity, 
or between mono- and poly-ubiquitinated states, could put 
deacetylases center stage as regulators of protein degradation 
dynamics (119).
Finally, proteomics approaches have identified several 
functional phosphorylation sites on AurA (most of them 
autophosphorylation sites), reviewed recently elsewhere (4). 
The most interesting from the point of view of Aurora stability 
is phosphorylation on the serine immediately downstream of the 
QRVL motif (S51 in human AurA), which appears to regulate the 
degron function of the A-box since phosphomimic mutation of 
this residue (S51D) stabilizes AurA in mitotic exit as efficiently 
as removal of the A-box (67, 79, 81, 120) (Figure 3B). This PTM 
has therefore been proposed to control the degradation of AurA 
at the end of mitosis (79, 81, 120). However, replacement of S51 
with a non-phosphorylatable residue (S51A) does not alter the 
timing of degradation of AurA during mitotic exit (Figure 3B). 
Dephosphorylation on this residue would therefore be a permis-
sive state, rather than the trigger of AurA destruction.
The serine residue S4, adjacent to the mitotic exit-specific 
ubiquitin acceptor lysine K5, is also phosphorylated in  vivo 
(121) and phosphomimic replacement increases ubiquitination 
efficiency on the neighboring lysine (101).
interactors of Aurora Kinases
AurA has multiple interactors, many of which, like TPX2 (25), are 
reported to modulate AurA levels through ubiquitin-dependent 
and -independent pathways. There is limited information about 
modulators of AurB stability, probably reflecting that AurB levels 
are effectively suppressed in interphase. Examples of interactors 
that influence AurA stability are Nedd9/HEF1, Pleckstrin-
homology-like domain protein PHDLA1, PUM2, LIMK2, and 
FAF1 (122–126), and in many cases, this stabilization occurs 
through competition for access to regions of AurA usually tar-
geted by the UPS.
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However, the switch-like function of the pS51 PTM in sta-
bilizing AurA may provide another route to modifying AurA 
turnover: recent studies by Erica Golemis and colleagues show 
that AurA can be activated through Ca2+-induced binding of 
Calmodulin (CaM) to the A-box region, and that CaM bind-
ing depends on the presence of serine residues, including S51, 
that are phosphorylated under the same conditions (127, 128). 
CaM binding to pS51 can be predicted therefore to stabilize 
AurA by blocking access to the A-box region. In this model of 
AurA regulation, autophosphorylation of AurA on S51 con-
nects activity and stability and allows for functionally relevant 
stabilization of active forms of the kinase through Ca2+-mediated 
signaling. There are reports that CaM also binds to AurB (127, 
129), although in this case, it is proposed that AurB is stabilized 
through competition for FBXL2 access to a region that does not 
include the A-box (129).
OTHeR UPS COMPONeNTS TARGeTiNG 
AURORA KiNASe
Although the APC/C appears to be the major E3 regulating 
Aurora kinase levels in vivo and destroys most of the detectable 
Aurora kinase in cells that exit mitosis, a small pool of AurA is 
thought to remain to fulfill interphase functions, either protected 
from APC/C-mediated destruction (perhaps through activity of 
a DUB, or through sequestering in the cytoplasm) or a newly 
synthesized pool as cells return to interphase. So, are there UPS 
components that turn over Aurora kinases in interphase cells? 
Candidate E3 ubiquitin ligases are CHFR, shown to target AurA 
both in vitro and in vivo (130), the BRCA1-associated BARD1 
that interacts with AurB (131), and SCF complexes containing a 
number of reported F-box proteins. FBXW7, FBXL7, and FBXL2 
are all reported to target Aurora kinases (53, 132–135), but it is 
not clear how well in vitro targeting predicts in vivo pathways, 
especially since the effects of overexpressing or depleting F-box 
proteins on global levels of Aurora kinases are frequently rather 
modest. It seems likely that small subpopulations are being 
targeted in each case (for example, FBXL7 localizes to the cen-
trosomes), as part of the complex spatial organization of kinase 
activity that underlies the multiple and divergent functions of 
these kinases. Interestingly though, dramatic stabilization of 
AurA is seen after treatment of cells with GSK3B inhibitor (136). 
In this study, GSK3B was proposed to promote FBXW7 target-
ing of AurA through priming a phospho-degron located in the 
kinase domain. However, phosphorylation of AurA by GSK3B 
on S283/4 is known to promote autophosphorylation on S342 
that is inhibitory to AurA activity (137), making it likely that 
GSK3B can govern AurA stability indirectly through conforma-
tional effects.
Dramatic effects on AurA levels are also reported in response 
to a factor called AURKAIP1, an AurA-interacting protein that 
promotes AurA destruction in a ubiquitin-independent man-
ner. AURKAIP1 may direct AurA to the proteasome through an 
interaction that competes with the ubiquitination machinery, 
since polyubiquitination is abolished upon overexpression of 
AURKAIP1 (138). However, AURKAIP1 turns out to be a mito-
chondrial ribosomal protein (139), such that the physiological 
relevance of these observations remains to be demonstrated. 
Finally, another interesting study reported that AurA is a 
substrate for the ubiquitin conjugating enzyme Ube2N, with 
which it interacts directly through an N-terminal domain that 
requires the residue F31. An F31I polymorphism that has lost 
Ube2N interaction is preferentially amplified in tumors (140), 
raising the still unanswered question of whether increased 
stability of AurA F31I could explain its role in colon cancer 
susceptibility.
CONCLUSiON
Aurora activity is a major regulator of the cell cycle, with a sepa-
ration of functions between paralogous Aurora kinases whose 
degradation kinetics in vertebrates have apparently evolved hand 
in hand with their specialization. The distribution of functions 
of the ancestral Aurora between two more specialized paralogs 
is a process that phylogenies indicate to have occurred more 
than once in eukaryotic lineages (12): Aurora kinases A and B in 
vertebrates, and the two Aurora kinases in flies and worms, arose 
via independent duplication events, following similar pathways 
toward specification of function. Such convergent evolution 
of Auroras suggests positive selection for specialization of two 
pools of Aurora kinase. While the kinase activity of the paralogs 
remains conserved, the regulatory modules including short 
linear motifs in their disordered regions, have largely diverged. 
We suggest this could be linked to the importance of differentially 
regulating pools of Aurora kinase activity in time. Although not 
well studied in other species, differential proteolysis is a feature 
of human Aurora kinases that strictly depends on these divergent 
terminal regions. While different interactors can achieve spatial 
regulation of Aurora kinase activity, differential proteolysis adds 
complexity to the control of Aurora kinase activity in a temporal 
domain.
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